Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra W Cowan-Jacob

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Nature Reviews. Cancer|April 26, 2007
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemiaEllen Weisberg, Paul W Manley, Sandra W Cowan-Jacob, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 4, 2003
Structure of rabbit-muscle glyceraldehyde-3-phosphate dehydrogenaseSandra W Cowan-Jacob, Markus Kaufmann, Anthony N Anselmo, et al.
Blood|February 17, 2007
Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis studyArghya Ray, Sandra W Cowan-Jacob, Paul W Manley, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 3, 2017
The impact of structural biology in medicine illustrated with four case studiesTiancen Hu, Elizabeth R Sprague, Michelle Fodor, et al.
Journal of Medicinal Chemistry|May 24, 2022
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved DrugMingxing Teng, Marlise R Luskin, Sandra W Cowan-Jacob, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinasesPaul W Manley, Werner Breitenstein, Josef Brüggen, et al.
Structure (London, England : 1993)|June 9, 2005
The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activationSandra W Cowan-Jacob, Gabriele Fendrich, Paul W Manley, et al.
The Journal of Biological Chemistry|April 25, 2008
Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinibNavratna Vajpai, André Strauss, Gabriele Fendrich, et al.
Biomolecular NMR Assignments|July 29, 2009
Backbone NMR resonance assignment of the Abelson kinase domain in complex with imatinibNavratna Vajpai, André Strauss, Gabriele Fendrich, et al.
Angewandte Chemie (International Ed. in English)|October 18, 2022
Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase"Wolfgang Jahnke, Johannes Paladini, Judith M Habazettl, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Nature Reviews. Cancer|April 26, 2007
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemiaEllen Weisberg, Paul W Manley, Sandra W Cowan-Jacob, et al.
Acta Crystallographica. Section D, Biological Crystallography|December 4, 2003
Structure of rabbit-muscle glyceraldehyde-3-phosphate dehydrogenaseSandra W Cowan-Jacob, Markus Kaufmann, Anthony N Anselmo, et al.
Blood|February 17, 2007
Identification of BCR-ABL point mutations conferring resistance to the Abl kinase inhibitor AMN107 (nilotinib) by a random mutagenesis studyArghya Ray, Sandra W Cowan-Jacob, Paul W Manley, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 3, 2017
The impact of structural biology in medicine illustrated with four case studiesTiancen Hu, Elizabeth R Sprague, Michelle Fodor, et al.
Journal of Medicinal Chemistry|May 24, 2022
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved DrugMingxing Teng, Marlise R Luskin, Sandra W Cowan-Jacob, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinasesPaul W Manley, Werner Breitenstein, Josef Brüggen, et al.
Structure (London, England : 1993)|June 9, 2005
The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activationSandra W Cowan-Jacob, Gabriele Fendrich, Paul W Manley, et al.
The Journal of Biological Chemistry|April 25, 2008
Solution conformations and dynamics of ABL kinase-inhibitor complexes determined by NMR substantiate the different binding modes of imatinib/nilotinib and dasatinibNavratna Vajpai, André Strauss, Gabriele Fendrich, et al.
Biomolecular NMR Assignments|July 29, 2009
Backbone NMR resonance assignment of the Abelson kinase domain in complex with imatinibNavratna Vajpai, André Strauss, Gabriele Fendrich, et al.
Angewandte Chemie (International Ed. in English)|October 18, 2022
Correspondence on "Synergy and Antagonism between Allosteric and Active-Site Inhibitors of Abl Tyrosine Kinase"Wolfgang Jahnke, Johannes Paladini, Judith M Habazettl, et al.
Pageof 4